Cipropride, a new anti-emetic agent, was administered to forty-six subjects with a view to preventing Dacarbazine- and Cis-platinium-induced nausea and vomiting. From a total number of 196 cytostatic courses of treatment results were assessed as excellent and good in, respectively, 18% and 71.4% of cases.
Get full access to this article
View all access options for this article.
References
1.
HermanT S (1979) Superiority of Nabilone over prochlorperazine as an anti-emetic in patients receiving cancer chemotherapy. New England Journal of Medicine, 300, 23, 1295.
2.
SallanS E (1980) Anti-emetics in patients receiving chemotherapy for cancer. New England Journal of Medicine, 302, 3, 135.
3.
ThebaultJ J (1980) Pre-clinical efficacy testing of cipropride in normal volunteers. Paper presented at the 14th Annual Meeting of European Society for Clinical Investigation. Salzburg (Austria), 24–26 April 1980. Abstract 218.
